Skip to content
akaturk Academic measurement

Academician

ASUMAN ÇELEBİ

Doktor Öğretim Üyesi

Bahçeşehir Üniversitesi

Articles 11 YÖKSİS 11 · OpenAlex 0 Total citations 35 h-index 2 · OpenAlex Q1 articles 6 Scopus · WoS Q1 3
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 11
YÖKSİS11 OpenAlex0
Projects 1
Books 0
Proceedings 0

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 0 + YÖKSİS · co-author record: 2
h-index 2
i10-index
1
Total citations
35
Per article
17.5
FWCI
2.76
1.00 = world average
World top 1%
0
World top 10%
1

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 2 articles (35 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Index quartiles

?
Scopus (SJR) 10
  • Q1 6 %60.0
  • Q2 3 %30.0
  • Q3 1 %10.0
  • Q4 0 %0.0
WoS (JCR) 10
  • Q1 3 %30.0
  • Q2 6 %60.0
  • Q3 1 %10.0
  • Q4 0 %0.0
TR Index 1 articles
Other counts

Scopus (SJR)

  • YÖKSİS rows 10

WoS (JCR)

  • YÖKSİS rows 10

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

11articles

Journals with publications

11 journals

Narrow down

Scopus (SJR)
Q16 Q23 Q31 Q40
WoS (JCR)
Q13 Q26 Q31 Q40
TR Index

Article list

  1. 2026 Disrupting Redox Balance: A Redox-Based Strategy to Combat Temozolomide Resistance in Glioblastoma Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/0118715206470620260527200257 YÖKSİS SJR Q3 JCR Q3
  2. 2026 Targeting BCL-2 through Deep Learning-Based Drug Repurposing: A Multimodal Approach Combining Diffusion-Based Generative Modeling, Neural Relational Inference, and In Vitro Validation Journal of Chemical Informationand Modeling DOI 10.1021/acs.jcim.6c01299 YÖKSİS SJR Q1 JCR Q1
  3. 2026 Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma The Journal of Pharmacology and Experimental Therapeutics DOI 10.1016/j.jpet.2026.103811 YÖKSİS SJR Q2 JCR Q2
  4. 2025 In vitro evaluation of the therapeutic efficacy of Moringa oleifera and oxaliplatin in 3D printed polycaprolactone/gelatin implantable patches: A potential strategy for overcoming drug resistance in colorectal cancer treatment International Journal of Biological Macromolecules DOI 10.1016/j.ijbiomac.2025.144129 YÖKSİS SJR Q1 JCR Q1
  5. 2024 Synthesis of Tryptamine-Thiazolidin-4-one Derivatives and the Combined In Silico and In Vitro Evaluation of their Biological Activity and Cytotoxicity ACS Omega DOI 10.1021/acsomega.4c04456 YÖKSİS SJR Q1 JCR Q2
  6. 2022 Glycopolymer and Poly(β-amino ester)-Based Amphiphilic Block Copolymer as a Drug Carrier Biomacromolecules DOI 10.1021/acs.biomac.2c01076 YÖKSİS SJR Q1 JCR Q1
  7. 2022 A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth Cell Death Discovery DOI 10.1038/s41420-022-01225-9 YÖKSİS SJR Q1 JCR Q2
  8. 2022 Investigation of Toll-like Receptor-2, -3 and -4 Gene Expressions in Larynx Squamous Cell Carcinoma Turkish Archives of Otorhinolaryngology DOI 10.4274/tao.2022.2022-6-17 YÖKSİS TR Index
  9. 2021 No Tumor Suppressor Role for LKB1 in Prostate Cancer DNA and Cell Biology DOI 10.1089/dna.2021.0274 YÖKSİS SJR Q2 JCR Q2
  10. 2020 Silencing of Wwox Increases Nuclear Import of Dvl proteins in Head and Neck Cancer Journal of Cancer DOI 10.7150/jca.40840 YÖKSİS SJR Q2 JCR Q2
  11. 2019 The investigation of hyaluronic acid and hyaluronidase‐1 levels as tumour marker in larynx cancer Clinical Otolaryngology DOI 10.1111/coa.13390 YÖKSİS SJR Q1 JCR Q2

← Back to academicians